Loading…
Clinical Pathways Congress 2018
Attending this event?
View analytic
avatar for Alan Balch, PhD

Alan Balch, PhD

Chief Executive Officer, Patient Advocate Foundation
avatar for Linda Bosserman, MD, FASCO, FACP

Linda Bosserman, MD, FASCO, FACP

Clinical Assistant Professor, City of Hope Medical Group, Inc., Duarte, California
avatar for Susana Campos, MD

Susana Campos, MD

Assistant Professor of Medicine Harvard Medical School Dana Farber Cancer Institute Boston, Massachusetts
DC

Dana Chase, MD, FACOG

Arizona Oncology
avatar for Robert Daly, MD, MBA

Robert Daly, MD, MBA

Assistant Attending Physician, Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York
avatar for Stephen B. Edge, MD, FACS, FASCO

Stephen B. Edge, MD, FACS, FASCO

Vice President, Healthcare Outcomes & Policy, Professor of Oncology, Surgeon, Department of Surgical Oncology, Breast Service, Roswell Park Comprehensive Cancer Center, Professor of Surgery, Jacobs School of Medicine, University of Buffalo, Buffalo, New York
avatar for Aymen Elfiky, MD, MSc, MBA

Aymen Elfiky, MD, MSc, MBA

Chief, Division of Oncology & Hematology Director of Analytics, Department of Medicine The Brooklyn Hospital Center –Mt. Sinai Health System
avatar for Andrew Hertler, MD, FACP

Andrew Hertler, MD, FACP

Chief Medical Officer, New Century Health, Brea, California
avatar for David Hughes

David Hughes

Senior Clinical Data Scientist, Seattle Cancer Care Alliance, Seattle. Washington
avatar for David Jackman, MD

David Jackman, MD

Medical Director of Clinical Pathways, Dana-Farber Cancer Institute, Senior Physician, Thoracic Oncology, Dana-Farber Cancer Institute, Assistant Professor, Harvard Medical School
avatar for Barbara L. McAneny, MD, MACP, FASCO

Barbara L. McAneny, MD, MACP, FASCO

President American Medical Association, CEO, New Mexico Cancer Center, CEO, Innovation Oncology Business Solutions (IOBS), Albuquerque, New Mexico
avatar for Joan S. McClure, MS

Joan S. McClure, MS

Former Senior Vice President, Clinical Information and Publications, National Comprehensive Cancer Network (NCCN)
avatar for Amir T. Fathi MD

Amir T. Fathi MD

Director, Leukemia Program Massachusetts General Hospital Assistant Professor of Medicine Harvard Medical School, Boston, Massachusetts
TK

Thomas Krivak MD

Associate Director, Department of Gynecological Oncology, Western Pennsylvania Hospital Clinical Professor, Department of Obstetrics and Gynecology, Temple University Vice Chair, Director of Research and Strategic Planning, Western Pennsylvania Hospital
avatar for Deborah Christensen MSN, APRN, AOCNS, HNB-BC

Deborah Christensen MSN, APRN, AOCNS, HNB-BC

Intermountain Healthcare System, Lead Oncology Navigation, Oncology Nurse Navigator, Intermountain Cancer Center, St. George, Utah
avatar for Andrew Norden, MD, MPH, MBA

Andrew Norden, MD, MPH, MBA

Chief Medical Officer, Cota Healthcare, New York, New York
avatar for Ray Page, DO, PhD, FACOI

Ray Page, DO, PhD, FACOI

President & Director of Research, The Center for Cancer and Blood Disorders, Fort Worth, Texas
avatar for Gary Palmer, MD, JD, MBA, MPH

Gary Palmer, MD, JD, MBA, MPH

Chief Medical Officer, Tempus, Inc., Chicago, Illinois
avatar for Sandeep

Sandeep "Bobby" Reddy, MD

Chief Medical Officer, NantHealth
avatar for Michael A. Savin, MD

Michael A. Savin, MD

Assistant Professor, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, Oregon
avatar for Winston Wong, PharmD

Winston Wong, PharmD

President, W-Squared Group, Longboat Key, Florida
avatar for Andrew York, PharmD, JD

Andrew York, PharmD, JD

Social Science Research Analyst, Patient Care Models Group
Center for Medicare and Medicaid Innovation (CMMI), CMS
avatar for Robin T. Zon, MD, FACP, FASCO

Robin T. Zon, MD, FACP, FASCO

Vice President, Finance & Quality Chair
Michiana Hematology-Oncology, PC